Registrieren

Registierung erfolgt in Kürze...
Fleebs-Logo
Details werden geladen...

FDA Approves Durvalumab With Enfortumab Vedotin for MIBC

With the approval, there's a rival to perioperative pembrolizumab with enfortumab vedotin for patients with cisplatin-ineligible muscle-invasive bladder cancer.